2009•Chongqing yixueRequires access

Clinical observation of treatment of liver cirrhosis with low virus load hepatitis B by lamivudine.

Linyan Tao, Yu HaoDong, Zhonghe Liu

Open publisher page 0 citations

Abstract

Objective To investigate the therapeutic efficacy of low virus load chronic hepatitis B by lamivudine.Methods Forty-seven patients of active liver cirrhosis with chronic hepatitis B(HBV-DNA 5.0×102-1.0×104 copies/mL) were randomly divided into two groups.The therapy group had twenty-four patients,the control group had twenty-three patients.Using the treatment of liver protection and supporting to both two groups,but lamivudine was used in therapy group,100mg q.d.,at least 1.5 years.Results The level of TBIL and ALT in two groups was decreased after 1.5 years,the score of Child-Pugh was degraded,the difference had significance.But the control group had a little change.The quantitation of HBV-DNA was negative in therapy group,and unobvious in control group.Conclusion Using lamivudine to treat liver cirrhosis with low virus load chronic hepatitis B has certain therapeutic effect.

About this research paper

What this paper is about

Objective To investigate the therapeutic efficacy of low virus load chronic hepatitis B by lamivudine.Methods Forty-seven patients of active liver cirrhosis with chronic hepatitis B(HBV-DNA 5.0×102-1.0×104 copies/mL) were randomly divided into two groups.The therapy group had twenty-four patients,the control group had twenty-three patients.Using the treatment of liver protection and supporting to both two groups,but lamivudine was used in therapy group,100mg q.d.,at least 1.5 years.Results The level of TBIL and ALT in two groups was decreased after 1.5 years,the score of Child-Pugh was degraded,the difference had significance.But the control group had a little change.The quantitation of HBV-DNA was negative in therapy group,and unobvious in control group.Conclusion Using lamivudine to treat liver cirrhosis with low virus load chronic hepatitis B has certain therapeutic effect.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the therapeutic efficacy of low virus load chronic hepatitis B by lamivudine.Methods Forty-seven patients of active liver cirrhosis with chronic hepatitis B(HBV-DNA 5.0×102-1.0×104 copies/mL) were randomly divided into two groups.The therapy group had twenty-four patients,the control group had twenty-three patients.Using the treatment of liver protection and supporting to both two groups,but lamivudine was used in therapy group,100mg q.d.,at least 1.5 years.Results The level of TBIL and ALT in two groups was decreased after 1.5 years,the score of Child-Pugh was degraded,the difference had significance.But the control group had a little change.The quantitation of HBV-DNA was negative in therapy group,and unobvious in control group.Conclusion Using lamivudine to treat liver cirrhosis with low virus load chronic hepatitis B has certain therapeutic effect.

Key concepts: Lamivudine, Cirrhosis, Medicine, Gastroenterology, Internal medicine, Chronic hepatitis, Hepatitis B virus, Hepatitis B

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical observation of treatment of liver cirrhosis with low virus load hepatitis B by lamivudine. — Research Paper | ScholarLens